Biogen Inc (BIIB)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $37.46B
Last updated: Nov 17, 2026 at 11:04 AM ET
Biogen Inc (BIIB) Competitors
The companies most similar to Biogen are Bristol-Myers Squibb Company (BMY), Amgen (AMGN) and GSK (GSK). Biogen trades at 21.4x earnings, against a median of 14.5x for the 8 of these companies with a P/E. By market cap, Biogen ranks 10th of the 13 companies on this page; AbbVie (ABBV) is the largest at $521.50B.
Peer Comparison
BIIB's ROIC of 1.3% is below the peer median of 7.6%, and its revenue growth of 10.6% is above the median of 8.9%. It pays no dividend, against a peer median yield of 2.26%.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Biogen (BIIB) | $37.46B | 21.4x | 3.6x | 3.4% | 1.3% | 10.6% | 0.00% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| BeOne Medicines AG (ONC) | $47.58B | 50.0x | 18.7x | 13.9% | 7.5% | 33.8% | 0.00% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| Neurocrine Biosciences Inc (NBIX) | $16.94B | 18.4x | 4.5x | 19.0% | N/A | 41.2% | 0.00% |
| AbbVie Inc (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Grifols SA ADR (GRFS) | $5.91B | 9.9x | 0.7x | 6.4% | 7.6% | 9.4% | 1.08% |
| Peer median | $122.90B | 14.5x | 4.1x | 13.4% | 7.6% | 8.9% | 2.26% |
Similar Companies
These are the 12 companies most similar to Biogen, ranked by how closely their business, size, sector and industry match. The largest group, 9 of the 12, is in Drug Manufacturers - General; the other 3 span 2 industries.
| Company | About | Peers |
|---|---|---|
| Bristol-Myers Squibb Company (BMY)Drug Manufacturers - General | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Amgen Inc (AMGN)Drug Manufacturers - General | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| GSK plc (GSK)Drug Manufacturers - General | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| BeOne Medicines AG (ONC)Biotechnology | BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe... | ONC competitors |
| Sanofi ADR (SNY)Drug Manufacturers - General | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| Pfizer Inc (PFE)Drug Manufacturers - General | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| BridgeBio Pharma Inc (BBIO)Biotechnology | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| Gilead Sciences Inc (GILD)Drug Manufacturers - General | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| Novo Nordisk A/S (NVO)Drug Manufacturers - General | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| Neurocrine Biosciences Inc (NBIX)Drug Manufacturers - Specialty & Generic | Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological... | NBIX competitors |
| AbbVie Inc (ABBV)Drug Manufacturers - General | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. | ABBV competitors |
| Grifols SA ADR (GRFS)Drug Manufacturers - General | Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. | GRFS competitors |
Frequently Asked Questions About BIIB
Who are Biogen's main competitors?
The companies most similar to Biogen include Bristol-Myers Squibb Company (BMY), Amgen (AMGN), GSK (GSK), BeOne Medicines AG (ONC) and Sanofi ADR (SNY), listed from the closest match.
Who is Biogen's biggest competitor?
AbbVie (ABBV) is the largest of the similar companies at $521.50B; Bristol-Myers Squibb Company (BMY) is the closest match by business profile, size, sector and industry.
How does BIIB stock compare with its competitors?
BIIB's P/E is 21.4x against a peer median of 14.5x; its P/S is 3.6x against a peer median of 4.1x; its net margin is 3.4% against a peer median of 13.4%.
Which of Biogen's competitors pays a higher dividend?
Biogen pays no dividend. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD) and Grifols SA ADR (GRFS) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.
Is Biogen bigger than its competitors?
No. Biogen is 10th by market cap among the 13 companies on this page; the largest is AbbVie (ABBV) at $521.50B.
BIIB pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors